<html><head></head><body><h1>Tobrex Ophthalmic Ointment</h1><p class="drug-subtitle"><b>Generic Name:</b> tobramycin<br/>
<b>Dosage Form:</b> ophthalmic ointment<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Dosage</li>
<li>Professional</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Warnings</li>
<li>Patient Counseling Information</li>
<li>Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><h2>DESCRIPTION</h2><p class="First">TOBREX<span class="Sup">®</span> (tobramycin ophthalmic ointment) 0.3% is a sterile topical ophthalmic antibiotic formulation prepared specifically for topical therapy of external ophthalmic infections.</p><p><span class="Bold">Each gram of TOBREX (tobramycin ophthalmic ointment) 0.3% contains: Active:</span> tobramycin 0.3% (3 mg). <span class="Bold">Preservative:</span> chlorobutanol 0.5%. <span class="Bold">Inactives:</span> mineral oil, white petrolatum.</p><p>Tobramycin is a water-soluble aminoglycoside antibiotic active against a wide variety of gram-negative and gram-positive ophthalmic pathogens.</p><p>The chemical structure of tobramycin is:</p><p>Molecular Formula:</p><p>C<span class="Sub">18</span>H<span class="Sub">37</span>N<span class="Sub">5</span>O<span class="Sub">9</span></p><p>Molecular Weight: 467.52</p><p>Chemical Name:</p><p>0-{3-amino-3-deoxy-α-D-gluco-pyranosyl-(1→4) }-0-{2,6-diamino-2,3,6-trideoxy-α-D-ribohexo-pyranosyl-(1→6) }-2-deoxystreptamine.</p><h2>CLINICAL PHARMACOLOGY</h2><p class="First"><span class="Italics">In Vitro Data: In vitro</span> studies have demonstrated tobramycin is active against susceptible strains of the following microorganisms: Staphylococci, including <span class="Italics">S. aureus</span> and <span class="Italics">S. epidermidis</span> (coagulase-positive and coagulase-negative), including penicillin-resistant strains.</p><p>Streptococci, including some of the Group A-beta-hemolytic species, some nonhemolytic species, and some <span class="Italics">Streptococcus pneumoniae</span>.</p><p><span class="Italics">Pseudomonas aeruginosa</span>, <span class="Italics">Escherichia coli, Klebsiella pneumoniae</span>, <span class="Italics">Enterobacter aerogenes</span>, <span class="Italics">Proteus mirabilis</span>, <span class="Italics">Morganella morganii</span>, most <span class="Italics">Proteus vulgaris</span> strains, <span class="Italics">Haemophilus influenzae</span> and <span class="Italics">H. aegyptius</span>, <span class="Italics">Moraxella lacunata</span>, <span class="Italics">Acinetobacter calcoaceticus</span> and some <span class="Italics">Neisseria species</span>. Bacterial susceptibility studies demonstrate that in some cases, microorganisms resistant to gentamicin retain susceptibility to tobramycin.</p><h2>INDICATIONS AND USAGE</h2><p class="First">TOBREX<span class="Sup">®</span> (tobramycin ophthalmic ointment) 0.3 % is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. Appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of TOBREX (tobramycin ophthalmic ointment) 0.3%. Clinical studies have shown tobramycin to be safe and effective for use in children.</p><h2>CONTRAINDICATIONS</h2><p class="First">TOBREX (tobramycin ophthalmic ointment) 0.3 % is contraindicated in patients with known hypersensitivity to any of its components.</p><h2>WARNINGS</h2><p class="First">NOT FOR INJECTION INTO THE EYE. Sensitivity to topically applied aminoglycosides may occur in some patients. Severity of hypersensitivity reactions may vary from local effects to generalized reactions such as erythema, itching, urticaria, skin rash, anaphylaxis, anaphylactoid reactions, or bullous reactions. If a sensitivity reaction to TOBREX (tobramycin ophthalmic ointment) 0.3% occurs, discontinue use.</p><h2>PRECAUTIONS</h2><p class="First"><span class="Bold">General:</span> As with other antibiotic preparations, prolonged use may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be initiated. Ophthalmic ointments may retard corneal wound healing.</p><p>Cross-sensitivity to other aminoglycoside antibiotics may occur; if hypersensitivity develops with this product, discontinue use and institute appropriate therapy.</p><p>Patients should be advised not to wear contact lenses if they have signs and symptoms of ocular infections.</p><p class="First"><span class="Bold">Information for Patients:</span> Do not touch tube tip to any surface, as this may contaminate the ointment.</p><p><span class="Bold">Do not use the product if the imprinted carton seals have been damaged, or removed.</span></p><p class="First"><span class="Bold">Pregnancy:</span> Reproduction studies in three types of animals at doses up to thirty-three times the normal human systemic dose have revealed no evidence of impaired fertility or harm to the fetus due to tobramycin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</p><p class="First"><span class="Bold">Nursing Mothers:</span> Because of the potential for adverse reactions in nursing infants from TOBREX<span class="Sup">®</span> (tobramycin ophthalmic ointment) 0.3%, a decision should be made whether to discontinue nursing the infant or discontinue the drug, taking into account the importance of the drug to the mother.</p><p class="First"><span class="Bold">Pediatric Use:</span> Safety and effectiveness in pediatric patients below the age of 2 months has not been established.</p><p class="First"><span class="Bold">Geriatric Use:</span> No overall clinical differences in safety or effectiveness have been observed between the elderly and other adult patients.</p><p class="First"><span class="Bold">ADVERSE REACTIONS:</span> The most frequent adverse reactions to TOBREX (tobramycin ophthalmic ointment) 0.3% are hypersensitivity and localized ocular toxicity, including lid itching and swelling, and conjunctival erythema. These reactions occur in less than three of 100 patients treated with TOBREX<span class="Sup">®</span> (tobramycin ophthalmic ointment) 0.3%.</p><p class="First"><span class="Bold">Postmarketing Experience:</span> Additional adverse reactions identified from postmarketing use include anaphylactic reaction, Stevens-Johnson syndrome, and erythema multiforme.</p><h2>DOSAGE AND ADMINISTRATION</h2><p class="First">In mild to moderate disease, apply a half-inch ribbon into the affected eye(s) 2 or 3 times per day. In severe infections, instill a half-inch ribbon into the affected eye(s) every 3 to 4 hours until improvement, following which treatment should be reduced prior to discontinuation.</p><p>How to Apply TOBREX (tobramycin ophthalmic ointment) 0.3%:</p><p>1. Tilt your head back.</p><p>2. Place a finger on your cheek just under your eye and gently pull down until a ''V'' pocket is formed between your eyeball and your lower lid.</p><p>3. Place a small amount (about ½ inch) of TOBREX<span class="Sup">®</span> (tobramycin ophthalmic ointment) 0.3% in the ''V'' pocket. Do not let the tip of the tube touch your eye.</p><p>4. Look downward before closing your eye.</p><h2>HOW SUPPLIED</h2><p class="First">TOBREX (tobramycin ophthalmic ointment) 0.3% is supplied as a 3.5 g sterile ointment in an aluminum tube with a white polyethylene tip and white polyethylene cap as follows:</p><p>3.5 g containing tobramycin 0.3% (3 mg/g)..... NDC 0065-0644-35</p><p><span class="Bold">Storage:</span> Store at 2°C to 25°C (36°F to 77°F).</p><p>After opening, TOBREX (tobramycin ophthalmic ointment) 0.3% can be used until the expiration date on the tube.</p><p>Revised: 4/2020</p><p>Distributed by:<br/>
Novartis Pharmaceuticals Corporation<br/>
East Hanover, New Jersey 07936</p><p>© Novartis</p><p>T2020-58</p><h2>PRINCIPAL DISPLAY PANEL</h2><p class="First"><span class="Bold">NDC</span> 0065-0644-35  Alcon<span class="Sup">®</span></p><p><span class="Bold">Tobrex</span><span class="Sup">®</span></p><p>(tobramycin ophthalmic</p><p>ointment) 0.3%</p><p><span class="Bold">Sterile 3.5 g Net Wt.</span></p><h2>More about tobramycin ophthalmic</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>6 Reviews</li>
<li>Drug class: ophthalmic anti-infectives</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tobramycin Ophthalmic &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Advanced Reading)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Tobramycin (Ophthalmic) &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Professional Patient Advice)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Tobramycin Ophthalmic Solution &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Conjunctivitis, Bacterial</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>